Women’s Health
Accelerator Program

Springboard’s Women’s Health Accelerator Program is for women-led companies seeking growth funding and connections to experts and strategic partners for product development and expansion. The program combines high-value events and workshops with an impactful community.

About the Program

Springboard’s Women’s Health Accelerator Program serves as a collective voice to drive women’s health innovation, investment and research. The Program gathers key industry leaders to promote greater gender-specific health data transparency and spur investment in women’s health innovation to produce better health outcomes for all.

Our program accelerates the growth of women led companies innovating in women’s health. Our mission is to address unmet needs in diseases, conditions, and indications that solely, predominantly, or differently impact the health of women.

  • Funding for femtech – defined as tech products or services which serve women’s health needs including fertility and sexual health — doubled in 2021 to $1.4 billion. (Source: Business Insider).
  • Only 5% of all digital health funding in 2021 went to women’s health tech companies (Source: Business Insider).
  • The femtech market is projected to exceed $60 billion by 2027 (Source: Emergen Research)

2025 Program Timeline

Application Launch

January 7, 2025

Applications Close

February 11, 2025

Virtual Interviews

February 24, 2025  – March 2, 2025

Intensive Bootcamp

March 31, 2025 – April 11, 2025

Advisory Period

May – June

Demo Day Showcase

June

What is Women’s Health?

Springboard’s Women’s Health Innovation Program identified The Framework of Women’s Health, which includes innovative solutions in Cognitive and Brain Health, Cardiovascular Health, Reproductive Health, Gynecological and Sexual Health, Aging and Bone Health, Oncology, and Autoimmune.

Women’s Health Program Sponsors

Women’s Health Program Community Partners

If you are interested in sponsoring or learning more about the program, please email:
Miranda Ewald, at [email protected]